Novo Nordisk A/S: Previously announced FDA Warning Letter published

February 05, 2013 09:37 ET | Source: Novo Nordisk A/S Novo Nordisk A/S

Attachments

Company announcement No 10 / 2013

Company announcement No 10 / 2013...

Recommended Reading

April 28, 2026 08:00 ET | Source: Novo Nordisk A/S

Novo Nordisk to present new data on Wegovy®, women with obesity and next-generation weight loss treatments at European Congress on Obesity

Novo Nordisk will present new clinical data and real-world evidence at the European Congress on Obesity, 12–15 May in Istanbul, Turkey.
Read More
April 27, 2026 04:56 ET | Source: Novo Nordisk A/S

Novo Nordisk A/S - share repurchase programme

Bagsværd, Denmark, 27 April 2026 – On 4 February 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...
Read More